TAL1 is a basic helix-loop-helix transcription factor that serves as a master regulator of hematopoiesis, with particular importance in erythroid differentiation 1. In normal hematopoiesis, TAL1 functions as a lineage-restricted transcription factor that is crucial for primitive hematopoiesis development and generation of all adult hematopoietic lineages 2. TAL1 exerts its function through formation of multiprotein complexes; it forms a core complex with E2A/HEB, GATA1/2, LIM-only proteins (LMO1/2), and LDB1 that binds to DNA regulatory elements 3. Within hematopoietic stem and progenitor cells, TAL1 occupancy at enhancers varies across cell types and associates with lineage-specific gene expression programs, with distinct combinations involving FLI1, RUNX1, and GATA2 controlling myeloid and erythroid differentiation 4. Clinically, TAL1 dysregulation is implicated in T-cell acute lymphoblastic leukemia (T-ALL), the most common molecular abnormality in this disease 2. Ectopic TAL1 and LMO expression cooperate to reprogram immature thymocytes into self-renewing preleukemic stem cells 3, and TAL1/LMO2 activity promotes dormant, chemotolerant leukemia-initiating cells that drive therapy resistance and relapse 5. Additionally, TAL1 cooperates with MYC and Aurora B kinase in a positive feedforward loop that reinforces T-cell leukemogenesis 6.